Health-Related Quality of Life and Disease Acceptance Among Women with Breast Cancer Pre- and Post-Neoadjuvant Chemotherapy
Cancers · 02.02.2025 · 17 (3) · 497
DOI: 10.3390/cancers17030497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 02.02.2025. Verfasst von Magdalena Konieczny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objective: The study aimed to evaluate disease acceptance and quality of life in women with breast cancer before and after receiving neoadjuvant chemotherapy.
Methods
The study included 211 women diagnosed with breast cancer who underwent neoadjuvant treatment. The following measures were utilized: the EORTC QLQ-C30 and QLQ-BR23 modules for quality of life assessment, the Acceptance of Illness Scale (AIS) questionnaire for evaluating disease acceptance, and a proprietary questionnaire. Assessments were conducted one week before the first chemotherapy session and three weeks after completing the chemotherapy. Statistical analysis was performed using STATISTICA v. 13.
Results
The respondents exhibited an average acceptance of their disease, both before (28.2 pts) and after chemotherapy (25.5 pts). A decline in disease acceptance was observed in nearly 59.2% of the patients following chemotherapy. Higher levels of disease acceptance were associated with a better quality of life. The quality of life for the studied women decreased after neoadjuvant chemotherapy, particularly in the following areas: physical functioning (p = 0.0000), social functioning (p = 0.0000), body image assessment (p = 0.0000), sexual satisfaction (p = 0.0000), nausea and vomiting (p = 0.0000), fatigue (p = 0.0000), loss of appetite (p = 0.0000), insomnia (p = 0.0000), pain (p = 0.0000), hair loss (p = 0.0000), and side effects of systemic treatment (p = 0.0000).
Conclusions
Post-neoadjuvant chemotherapy, a decline in disease acceptance and quality of life was observed among women with breast cancer in comparison with their pre-treatment status. Higher levels of disease acceptance were associated with a better quality of life. These findings may facilitate the creation of a more tailored care approach for women during and after chemotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.
- Department of Medical Biology, Institute of Medical Sciences, Medical College of Rzeszow University, Rejtana 16 C, 35-959 Rzeszów, Poland.
ORCID-Profile: Magdalena Konieczny, Dorota Bądziul
Zitieren
APA
Konieczny, M., Sawicka, J., Gąska, I., Kaczmar, E., Babuśka-Roczniak, M., & Bądziul, D. (2025). Health-Related Quality of Life and Disease Acceptance Among Women with Breast Cancer Pre- and Post-Neoadjuvant Chemotherapy. Cancers, 17(3), 497. https://doi.org/10.3390/cancers17030497
Vancouver
Konieczny M, Sawicka J, Gąska I, Kaczmar E, Babuśka-Roczniak M, Bądziul D. Health-Related Quality of Life and Disease Acceptance Among Women with Breast Cancer Pre- and Post-Neoadjuvant Chemotherapy. Cancers. 2025;17(3):497. doi:10.3390/cancers17030497
BibTeX
@article{Konieczny2025,
author = {Konieczny, Magdalena and Sawicka, Jolanta and Gąska, Izabela and Kaczmar, Elżbieta and Babuśka-Roczniak, Magdalena and Bądziul, Dorota},
title = {Health-Related Quality of Life and Disease Acceptance Among Women with Breast Cancer Pre- and Post-Neoadjuvant Chemotherapy},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {497},
doi = {10.3390/cancers17030497}
}
EUVIMED